MedPath

Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls.

Completed
Conditions
Healthy
Obstructive Sleep Apnea
Registration Number
NCT00291993
Lead Sponsor
Regional Hospital Holstebro
Brief Summary

Obstructive sleep apnea syndrome is complicated by considerable cardiovascular morbidity and mortality, at least partly due to hypertension. Nocturnal hypoxia, hypercapnia and acidosis stimulate chemoreceptors and presumably increased secretion of vasoactive hormones which might be responsible for hypertension in these patients.

The aim of this study is to measure the secretion of vasoactive hormones at night and to analyse the relationship between vasoactive hormones, oxygen saturation and the blood pressure at night.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Male and female Age 20-65 Obstructive sleep apnea

Exclusion Criteria

Drug or alcohol abuse Pregnancy or breast feeding Cancer Clinical signs or history of disease in the heart, lungs, kidney or endocrine organs Abnormal laboratory tests Albuminuria or glucosuria Aterial hypertension for healthy subjects

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Department of Medical Research, Holstebro Hospital

🇩🇰

Holstebro, Ringkoebing County, Denmark

Department of Medical Research

🇩🇰

Holstebro, Denmark

Holstebro Hospital, Department of Medical Research

🇩🇰

Holstebro, Denmark

© Copyright 2025. All Rights Reserved by MedPath